Hyperion Therapeutics Inc (HPTX.OQ)
20.66USD
18 Jun 2013
$-0.12 (-0.58%)
$20.78
$20.77
$20.77
$20.33
11,230
20,635
$26.50
$10.00
HPTX.OQ
About
Overall
| Beta: | -- |
| Market Cap (Mil.): | $414.07 |
| Shares Outstanding (Mil.): | 20.04 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| HPTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 39.38 | 31.28 |
| EPS (TTM): | -4.15 | -- | -- |
| ROI: | -91.48 | 2.42 | 18.90 |
| ROE: | -- | 3.64 | 19.80 |
FDA OKs Hyperion drug for serious genetic disorder
- U.S. health regulators on Friday approved a drug from Hyperion Therapeutics Inc designed to remove ammonia buildup from the blood of patients with enzyme deficiencies known as urea cycle disorders.
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $86.36 | +0.73 |
| Pfizer Inc. (PFE.N) | $29.40 | +0.24 |
| Novartis AG (NOVN.VX) | CHF67.00 | -0.15 |
| Merck & Co., Inc. (MRK.N) | $47.75 | -0.05 |
| Roche Holding Ltd. (ROG.VX) | CHF229.10 | +0.20 |
| Abbott Laboratories (ABT.N) | $37.51 | +0.62 |
| Bayer AG (BAYGn.DE) | €83.34 | -0.48 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €80.94 | -0.61 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
